More than 2,200 Australians were diagnosed with stomach cancer in 2020 and 1,140 died from the disease. Sadly, stomach cancer is often not diagnosed until it is at an advanced stage when it is more difficult to treat, and the five-year survival rate of less than 30 per cent.
What is stomach cancer?
Stomach cancer risk factors
Stomach cancer diagnosis
Our stomach cancer research
Late diagnosis is one of the biggest issues in stomach cancer. By uncovering how stomach cancer develops and spreads, our scientists’ goal is to save lives thorough better detection and treatments.
Keeping stomach cancer at bay
Prevention and molecular studies. Some people with H. pylori infection develop a rare form of cancer, known as MALT lymphoma, in which white blood cells accumulate in the stomach. Professor Ferrero’s group has identified a protein that prevents the accumulation of these cells in the stomach. Ongoing studies are focussed on identifying novel biomarkers and developing new therapies against this cancer.
Development of a vaccine against stomach cancer
A new therapeutic target for Helicobacter pylori-induced stomach cancer
Discovery of new mechanism behind stomach cancer
What does the immune response in stomach cancer mean?
Pro-inflammatory protein offers hope for a new treatment
Role of DNA sensors in stomach cancer
Inflammation and cancer
Stomach cancer collaborators
- Monash University
- Monash Health
- University of Newcastle
- University of Melbourne
- University of Florence
- University of Toronto
- University of Hohenheim
- Cardiff University
- Kanazawa University
- University of Adelaide
- Shanghai Jiao Tong University
- Duke-NUS Medical School
- UNC-Chapel Hill
- Harvard Medical School
Support for people with stomach cancer
Hudson Institute scientists cannot provide medical advice.
Find out more about stomach cancer.
Keep up-to-date with our latest discoveries